Green Eric Mark — SEC insider filings
SEC reporting owner CIK 1336007. 41 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2021-02-17 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 3,690 shares, $1,020,798 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 33 legs across 8 filings — 402,864 shares, $138,885,872 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 90.
- Largest priced transaction: sale of 64,132 shares @ $359.85 ($23,077,971) in WEST PHARMACEUTICAL SERVICES INC, filed 2024-02-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | President, CEO and Board Chair, Director | 20 | — | 33 legs · 402,864 sh · $138,885,872 | 54 |
| ECOLAB INC. (ECL) | Director | 21 | 2 legs · 3,690 sh · $1,020,798 | — | 36 |
Insider filings — Green Eric Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 131.17 @ $0 · Grant/award (A): 144.75 @ $276.36 | EDGAR |
| 2026-09-14 | 4 | ECOLAB INC. (ECL) | Purchase (P): 3,370 @ $276.58 · Purchase (P): 320 @ $277.29 | EDGAR |
| 2026-07-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 130.18 @ $0 · Grant/award (A): 143.65 @ $278.46 | EDGAR |
| 2026-05-19 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 732 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 137.82 @ $0 · Grant/award (A): 152.07 @ $263.03 | EDGAR |
| 2026-03-03 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 6,986 (derivative) @ $0 · Grant/award (A): 16,630 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 4,418.77 @ $0 · Tax withholding (F): 1,305.38 @ $243.19 · Option exercise (M): 1,318.81 · Tax withholding (F): 573.55 @ $248.26 · Option exercise (M): 1,318.81 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 128 @ $0 · Grant/award (A): 137.48 @ $263.68 | EDGAR |
| 2025-10-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 123.23 @ $0 · Grant/award (A): 132.37 @ $273.87 | EDGAR |
| 2025-07-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 126.18 @ $0 · Grant/award (A): 135.52 @ $267.48 | EDGAR |
| 2025-05-14 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 810 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 134.16 @ $0 · Grant/award (A): 144.10 @ $251.56 | EDGAR |
| 2025-02-20 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 2,460.99 @ $211 · Tax withholding (F): 700.30 @ $211 · Grant/award (A): 12,149 (derivative) @ $0 · Grant/award (A): 5,256 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 143.83 @ $0 · Grant/award (A): 154.49 @ $234.64 | EDGAR |
| 2024-10-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 132.70 @ $0 · Grant/award (A): 142.53 @ $254.34 | EDGAR |
| 2024-08-08 | 4/A | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 9,316 @ $57.38 · Option exercise (M): 15,684 @ $57.38 · Option exercise (M): 41,000 @ $59.64 · Sale (S): 9,316 @ $366.64 · Sale (S): 15,684 @ $366.66 · Sale (S): 41,000 @ $366.65 · +5 more | EDGAR |
| 2024-08-08 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 30,732 @ $59.64 · Sale (S): 30,732 @ $304.71 · Option exercise (M): 6,000 @ $59.64 · Option exercise (M): 30,732 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 141.31 @ $0 · Grant/award (A): 144.41 @ $238.84 | EDGAR |
| 2024-05-09 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 9,316 @ $57.38 · Option exercise (M): 15,684 @ $57.38 · Option exercise (M): 41,000 @ $59.64 · Sale (S): 9,316 @ $366.64 · Sale (S): 15,684 @ $366.66 · Sale (S): 41,000 @ $366.65 · +5 more | EDGAR |
| 2024-05-08 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 934 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 146.23 @ $0 · Grant/award (A): 135.39 @ $230.81 | EDGAR |
| 2024-02-29 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 64,132 @ $57.38 · Sale (S): 64,132 @ $359.85 · Option exercise (M): 9,000 @ $57.38 · Option exercise (M): 9,000 (derivative) @ $0 · Option exercise (M): 64,132 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 6,567 @ $0 · Grant/award (A): 25,221 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 157.33 @ $0 · Grant/award (A): 151.03 @ $198.63 | EDGAR |
| 2023-12-08 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Gift (G): 9,800 @ $343 | EDGAR |
| 2023-10-03 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 183.79 @ $0 · Grant/award (A): 176.44 @ $170.03 | EDGAR |
| 2023-08-10 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 50,000 @ $57.38 · Sale (S): 1,000 @ $389.62 · Sale (S): 4,500 @ $392.16 · Sale (S): 7,055 @ $393.13 · Sale (S): 8,329 @ $394.17 · Sale (S): 7,684 @ $395.07 · +5 more | EDGAR |
| 2023-07-05 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 168.12 @ $0 · Grant/award (A): 161.40 @ $185.88 | EDGAR |
| 2023-05-11 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 50,000 @ $57.38 · Sale (S): 14,157 @ $361.95 · Sale (S): 12,562 @ $362.93 · Sale (S): 12,648 @ $363.94 · Sale (S): 4,133 @ $364.76 · Sale (S): 500 @ $365.46 · +1 more | EDGAR |
| 2023-05-05 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 1,410 (derivative) @ $0 · Grant/award (A): 554 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 189.61 @ $0 · Grant/award (A): 182.03 @ $164.81 | EDGAR |
| 2023-03-09 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 50,000 @ $57.38 · Sale (S): 3,154 @ $320.60 · Sale (S): 7,685 @ $321.61 · Sale (S): 26,753 @ $322.49 · Sale (S): 5,277 @ $323.38 · Sale (S): 1,131 @ $324.29 · +1 more | EDGAR |
| 2023-02-23 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 14,783 @ $306.68 · Grant/award (A): 29,872 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | ECOLAB INC. (ECL) | Grant/award (A): 56 @ $0 | EDGAR |
| 2022-12-08 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Option exercise (M): 50,000 @ $57.38 · Sale (S): 6,746 @ $236.95 · Sale (S): 9,408 @ $237.67 · Sale (S): 6,312 @ $238.83 · Sale (S): 10,752 @ $239.70 · Sale (S): 9,682 @ $240.73 · +2 more | EDGAR |
| 2022-02-24 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 22,104 @ $369.13 | EDGAR |
| 2022-02-24 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 31,088 (derivative) @ $0 | EDGAR |
| 2022-02-14 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Tax withholding (F): 85 @ $391.20 | EDGAR |
| 2021-02-25 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 43,652 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 17,767 @ $272.65 | EDGAR |
| 2021-02-17 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Tax withholding (F): 92 @ $294.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1336007 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs